These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29403024)

  • 1. miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellular carcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition.
    Guo C; Zhao D; Zhang Q; Liu S; Sun MZ
    Sci Rep; 2018 Feb; 8(1):2375. PubMed ID: 29403024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma.
    Guo C; Gao C; Zhao D; Li J; Wang J; Sun X; Liu Q; Hao L; Greenaway FT; Tian Y; Liu S; Sun MZ
    J Exp Clin Cancer Res; 2020 Apr; 39(1):70. PubMed ID: 32326970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-429-CRKL axis regulates clear cell renal cell carcinoma malignant progression through SOS1/MEK/ERK/MMP2/MMP9 pathway.
    Wang J; Wang C; Li Q; Guo C; Sun W; Zhao D; Jiang S; Hao L; Tian Y; Liu S; Sun MZ
    Biomed Pharmacother; 2020 Jul; 127():110215. PubMed ID: 32413671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-30a suppresses tumor progression by blocking Ras/Raf/MEK/ERK signaling pathway in hepatocellular carcinoma.
    Zhou K; Luo X; Wang Y; Cao D; Sun G
    Biomed Pharmacother; 2017 Sep; 93():1025-1032. PubMed ID: 28732393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRKL but not CRKII contributes to hemin-induced erythroid differentiation of CML.
    Guo C; Lv X; Zhang Q; Yi L; Ren Y; Li Z; Yan J; Zheng S; Sun MZ; Liu S
    J Cell Mol Med; 2024 May; 28(9):e18308. PubMed ID: 38683131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
    Franke FC; Müller J; Abal M; Medina ED; Nitsche U; Weidmann H; Chardonnet S; Ninio E; Janssen KP
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):33-53. PubMed ID: 30480076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of Micro-429 on inhibition of cervical cancer cells through targeting ZEB1 and CRKL.
    Wang Y; Dong X; Hu B; Wang XJ; Wang Q; Wang WL
    Biomed Pharmacother; 2016 May; 80():311-321. PubMed ID: 27133071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crk-like adapter protein regulates CCL19/CCR7-mediated epithelial-to-mesenchymal transition via ERK signaling pathway in epithelial ovarian carcinomas.
    Cheng S; Guo J; Yang Q; Yang X
    Med Oncol; 2015 Mar; 32(3):47. PubMed ID: 25636509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma.
    Liu Z; Wang Y; Dou C; Xu M; Sun L; Wang L; Yao B; Li Q; Yang W; Tu K; Liu Q
    Theranostics; 2018; 8(17):4649-4663. PubMed ID: 30279729
    [No Abstract]   [Full Text] [Related]  

  • 10. MicroRNA-150 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting the GAB1-ERK axis.
    Sun W; Zhang Z; Wang J; Shang R; Zhou L; Wang X; Duan J; Ruan B; Gao Y; Dai B; Qu S; Liu W; Ding R; Wang L; Wang D; Dou K
    Oncotarget; 2016 Mar; 7(10):11595-608. PubMed ID: 26871477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long noncoding RNA
    Ren Y; Shang J; Li J; Liu W; Zhang Z; Yuan J; Yang M
    J Biol Chem; 2017 Oct; 292(43):17939-17949. PubMed ID: 28887306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA SNHG16 regulates cell behaviors through miR-542-3p/HNF4α axis via RAS/RAF/MEK/ERK signaling pathway in pediatric neuroblastoma cells.
    Deng D; Yang S; Wang X
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32412051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-124-3p Suppresses the Invasiveness and Metastasis of Hepatocarcinoma Cells
    Majid A; Wang J; Nawaz M; Abdul S; Ayesha M; Guo C; Liu Q; Liu S; Sun MZ
    Front Mol Biosci; 2020; 7():223. PubMed ID: 33094104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-379 Suppresses Cervical Cancer Cell Proliferation and Invasion by Directly Targeting V-crk Avian Sarcoma Virus CT10 Oncogene Homolog-Like (CRKL).
    Shi X; Xiao X; Yuan N; Zhang S; Yuan F; Wang X
    Oncol Res; 2018 Aug; 26(7):987-996. PubMed ID: 29295725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRKL promotes cell proliferation in gastric cancer and is negatively regulated by miR-126.
    Wang J; Chen X; Li P; Su L; Yu B; Cai Q; Li J; Yu Y; Liu B; Zhu Z
    Chem Biol Interact; 2013 Nov; 206(2):230-8. PubMed ID: 24055140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA
    Tong Y; Wang M; Dai Y; Bao D; Zhang J; Pan H
    Hum Gene Ther Clin Dev; 2019 Sep; 30(3):129-141. PubMed ID: 30963785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zic2 promotes tumor growth and metastasis via PAK4 in hepatocellular carcinoma.
    Lu SX; Zhang CZ; Luo RZ; Wang CH; Liu LL; Fu J; Zhang L; Wang H; Xie D; Yun JP
    Cancer Lett; 2017 Aug; 402():71-80. PubMed ID: 28577975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.
    Chen JS; Li HS; Huang JQ; Dong SH; Huang ZJ; Yi W; Zhan GF; Feng JT; Sun JC; Huang XH
    Cancer Lett; 2016 May; 375(1):73-83. PubMed ID: 26944318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.